OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
44
Results
Show all
Save search
Copy query
Show results for
Unknown
(44)
Publication Date
Release Date
2021
(7)
2019
(7)
2017
(6)
2018
(5)
2016
(3)
2012
(3)
2024
(2)
2020
(2)
2015
(2)
2010
(2)
2025
(1)
2022
(1)
2014
(1)
2013
(1)
2008
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
bla
KPC-3
Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
Not available
S-EPMC5328542
|
biostudies-literature
Cite
ABA Is Required for Plant Acclimation to a Combination of Salt and Heat Stress.
Not available
S-EPMC4733103
|
biostudies-literature
Cite
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant
Acinetobacter baumannii
.
Not available
S-EPMC8300792
|
biostudies-literature
Cite
Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in Escherichia coli-Caused Uncomplicated Urinary Tract Infection.
Not available
S-EPMC11327794
|
biostudies-literature
Cite
EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression.
Not available
S-EPMC4859522
|
biostudies-literature
Cite
Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections.
Not available
S-EPMC8678443
|
biostudies-literature
Cite
Review of results from the Tube Versus Trabeculectomy Study.
Not available
S-EPMC5584063
|
biostudies-literature
Cite
Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial.
Not available
S-EPMC4821633
|
biostudies-literature
Cite
Report on the sixth blind test of organic crystal structure prediction methods.
Not available
S-EPMC4971545
|
biostudies-literature
Cite
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.
Not available
S-EPMC9804266
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets